News

Coca-Cola inks new partnership to accelerate global production of PlantBottle packaging

BY Allison Cerra

ATLANTA — Coca-Cola has inked a partnership with JBF Industries to further expand production of the plant-based material used in Coca-Cola’s PlantBottle packaging.

Coca-Cola said the supply partnership will help the company continue its leadership in bringing renewable, lower-carbon plastics to the marketplace and move the company closer to its target of using PlantBottle packaging technology in all of its plastic bottles by 2020.

PlantBottle packaging is available in more than 24 countries worldwide and across a wide variety of Coca-Cola products, the company said. Since the package launched in 2009, its use has eliminated the equivalent of almost 100,000 metric tons of carbon dioxide emissions — the equivalent of 200,000 barrels of oil from Coca-Cola’s PET plastic packaging.

"The benefits of sustainable innovation are only fully realized when commercialized and put in the hands of consumers," Coca-Cola VP procurement and chief procurement officer Ronald Lewis said. "In 2009, we introduced the world to our PlantBottle package — the first recyclable PET plastic bottle made partially from plants. Today, Coca-Cola has sold more than 10 billion PlantBottle packages around the world that are less dependent on petroleum and have a lower carbon impact. We are pleased that our partnership with JBF Industries will help us further expand global production."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Natural Products Solutions expands men’s health supplement line with VirMax T

BY Michael Johnsen

TIMONIUM, Md. — Natural Products Solutions recently announced the launch of VirMax T testosterone booster as the newest addition to the VirMax line of supplements. VirMax T made its official debut in early October at the 2012 National Association of Convenience Stores in Las Vegas and it currently is available in Circle K stores nationwide and on Walgreens’ Drugstore.com site.

“VirMax products are among the top in the SymphonyIRI ratings,” NPS president and CEO Marty Gallant said. “Adding VirMax T helps position the VirMax line as a market leader for natural supplements in the men’s category.”

In January 2013, Walgreens also will begin featuring the product in stores across the country.

After age 30, a large percentage of men begin to experience a gradual decline in testosterone levels and these levels continue to decrease with age. Testosterone plays a key role in the development of reproductive tissues, such as the testis and prostate, and it can contribute to an increase in muscle and bone mass.

VirMax T was designed to help naturally restore testosterone levels within the body and its proprietary blend includes magnesium, tribulus and LJ100, an extract of the Tongkat ali herb. These ingredients also maintain normal muscle and nerve functions and help improve intimacy health.

This launch coincides with NPS’ recent nationwide marketing campaign and its partnership with John Salley, four-time NBA champion, television personality and wellness advocate. Salley serves as the spokesman for VirMax T and the VirMax line to assist with brand recognition and to help educate the public on their benefits.

“After his fourth championship, John became an advocate for men’s health issues and he began speaking at conferences and events around the country so we were happy to have him join our team,” Gallant said.

keyboard_arrow_downCOMMENTS

Leave a Reply

J.CARREY says:
Aug-09-2013 04:31 pm

thanks

c.cindrella says:
Oct-09-2012 08:11 am

Not only VirMax T, there is actually increase in other natural supplements usage on the whole. I get my natural supplements for good health at International Drug Mart. They have supplements for various disorders.

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Health officials, experts get vaccinated for flu as study highlights progress, gaps in vaccination efforts

BY Alaric DeArment

WASHINGTON — Flu vaccination rates have remained steady overall, but rates continue to vary between age groups and among states, according to data from a Centers for Disease Control and Prevention study published Thursday.

Leaders from the National Foundation for Infectious Diseases, CDC, American Pharmacists Association, American Medical Association and others gathered at the National Press Club in Washington Thursday morning, where public health officials and medical experts, including the Department of Health and Human Services’ assistant secretary for health, Howard Koh, received flu vaccinations.

The CDC study, announced to coincide with the event, showed that an estimated 128 million people, or 42% of the U.S. population, received flu vaccinations during the 2011-2012 season. Vaccination rates among children ages 6 months to 17 years remained steady, at 52%, with rates among those ages 6 to 23 months increasing to 75%, a 6% rise over the 2010-2011 season. But coverage of children also decreased with age: Among those ages 13 to 17 years, the rate remained at 34%. Meanwhile, adults ages 65 years and older showed rates of 65%, but that represented a decline from 74% in 2008-2009. Among pregnant women, rates increased from 30% in 2008-2009 to 47% in 2011-2012, and vaccination rates among children were comparable across ethnic groups, but disparities remained in the adult populations. The CDC reported noted that coverage remained below the goal rate of 80% for those ages 6 months to 65 years and 90% for those ages 65 years and older.

"The past three years have demonstrated that influenza is predictably unpredictable," Koh said. "When it comes to flu, we can’t look to the past to predict the future. Stay healthy — get vaccinated."

APhA chief strategy officer Mitchel Rothholz lauded the role pharmacists had played in vaccination efforts. Pharmacists in all 50 states, the District of Columbia and Puerto Rico can administer influenza vaccines.

"Pharmacists have been offering flu vaccines for nearly two decades, but the 2009 pandemic prompted greater collaboration throughout the immunization neighborhood, resulting in sustained public health gains," Rothholz said. "Pharmacists and pharmacists are playing a greater role within the immunization neighborhood in making vaccines and vaccine information more accessible to all community residents."

More than 85 million influenza vaccine doses were distributed as of Sept. 14, and manufacturers project that 135 million will be distributed during the season in pharmacies and other retail stores, doctor’s offices, public health clinics and other venues, according to the NFID.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?